ClinVar Miner

Submissions for variant NM_000527.5(LDLR):c.1773C>T (p.Asn591=)

gnomAD frequency: 0.33392  dbSNP: rs688
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 19
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000182338 SCV000269224 benign not specified 2015-12-31 criteria provided, single submitter clinical testing p.Asn591Asn in exon 12 of LDLR: This variant is not expected to have clinical si gnificance because it has been identified in 37.8% (45902/121396) of chromosomes tested by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.or g; dbSNP rs688).
LDLR-LOVD, British Heart Foundation RCV000237654 SCV000295647 benign Hypercholesterolemia, familial, 1 2016-03-25 criteria provided, single submitter literature only
PreventionGenetics, part of Exact Sciences RCV000182338 SCV000304688 benign not specified criteria provided, single submitter clinical testing
Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge RCV000237654 SCV000322974 benign Hypercholesterolemia, familial, 1 2016-03-01 criteria provided, single submitter research 19 Hmz + 62 htz / 125 non-FH individuals; MAF = 48,3% in 86 Spanish healthy individuals
Illumina Laboratory Services, Illumina RCV000237654 SCV000410537 benign Hypercholesterolemia, familial, 1 2018-03-06 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Color Diagnostics, LLC DBA Color Health RCV000237654 SCV000689767 benign Hypercholesterolemia, familial, 1 2017-06-22 criteria provided, single submitter clinical testing
Department of Human Genetics, Laborarztpraxis Dres. Walther, Weindel und Kollegen RCV000237654 SCV000987008 likely benign Hypercholesterolemia, familial, 1 2018-06-11 criteria provided, single submitter clinical testing Due to the increased occurrence of the mutation (>= 5%) and the current estimates of databases (LOVD 3), this variant is classified as likely benign.
Invitae RCV001275781 SCV001729840 benign Familial hypercholesterolemia 2024-02-01 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000237654 SCV001738023 benign Hypercholesterolemia, familial, 1 2021-06-10 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001812171 SCV002049915 benign not provided 2023-11-29 criteria provided, single submitter clinical testing
Molecular Genetics, Royal Melbourne Hospital RCV000237654 SCV002503848 benign Hypercholesterolemia, familial, 1 2020-11-20 criteria provided, single submitter clinical testing Population allele frequency is 38% (rs688, 106341/277102 alleles in gnomAD v2.0.2). Based on the classification scheme RMH ACMG Guidelines v1.1.1, this variant is classified as Benign. Following criteria met: BA1.
Ambry Genetics RCV002399653 SCV002714779 benign Cardiovascular phenotype 2015-12-08 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Fulgent Genetics, Fulgent Genetics RCV000237654 SCV002809584 benign Hypercholesterolemia, familial, 1 2022-03-25 criteria provided, single submitter clinical testing
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum RCV000237654 SCV000606510 benign Hypercholesterolemia, familial, 1 no assertion criteria provided research
Natera, Inc. RCV001275781 SCV001461318 benign Familial hypercholesterolemia 2020-09-16 no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000182338 SCV001743237 benign not specified no assertion criteria provided clinical testing
Clinical Genetics, Academic Medical Center RCV000182338 SCV001922080 benign not specified no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000182338 SCV001931172 benign not specified no assertion criteria provided clinical testing
Cohesion Phenomics RCV001275781 SCV003836767 benign Familial hypercholesterolemia 2023-02-09 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.